BioLizard has been listed as a Trends Gazelle

As a fast-growing company, BioLizard has been recognised as one of the companies to watch in 2025! ⭐️ 👀
For just one project at the intersection of data science and biology, you might require expertise spanning from the deep understanding of multi-omics and bioinformatics analysis, to applied skills in software engineering and data architecture and governance. At BioLizard, we’re dedicated to fostering this deep and broad expertise in our team of Lizards - and we’ve collected that knowledge here for you to explore.
Bio|Verse Navigator can accelerate data exploration and interpretation workflows multifold, reducing time-to-insight for researchers. The application combines advanced BioLizard’s bioinformatics expertise in handling various customer datasets with powerful visual analytics, capable of exploring ...
Data science is vastly changing the way we do research. Veterinary research is, however, still lagging behind its human counterpart. Why is this the case and can we learn from human health data to close this gap? Published by: BioVox on November 27, 2024 - link
Published by: European Biopharmaceutical Review on 23.10.2024. Link By Paul Vauterin, Chief Technology Officer at BioLizard In today’s life sciences industry, economic uncertainties are prompting a shift in investment focus. BioLizard addresses this challenge by empowering biotech companies to ...